(IN BRIEF) New research published in the European Heart Journal has shown that intermuscular fat, which accumulates between muscles, significantly increases the risk of heart disease, heart attack, and heart failure, regardless of body mass index (BMI). Led by Professor … Read the full press release
Posted in Business, Financial, France, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged body mass index, Brigham and Women's Hospital, cardiac risk assessment, Cardiovascular risk, chest pain, CMD, coronary microvascular dysfunction, Dr. Ranil de Silva, European Heart Journal, exercise, fatty muscle fraction, heart attack, heart disease, heart failure, Imperial College London, insulin resistance, intermuscular fat, lean muscle, metabolic syndrome, muscle fat, Nutrition, Obesity, PET/CT scanning, Professor Viviany Taqueti, shortness of breath, subcutaneous fat, treatment strategies, weight-loss therapies, WOMEN
(IN BRIEF) Evotec and Novo Nordisk’s LAB eN² program, a translational drug discovery accelerator, has selected its first three academic research projects focused on addressing cardiometabolic diseases. The projects, from Boston University, Harvard University in collaboration with Mass General Brigham, … Read the full press release
Posted in Business, Denmark, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Boston University, Cardiometabolic Research, Chronic kidney disease, Denmark, Dr. Thomas Hanke, Evotec, Harvard University, Joslin Diabetes Center, LAB eN² Program, Mass General Brigham, metabolic syndrome, Novo Nordisk, Obesity, partnership, type 1 diabetes, Uli Stilz
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?